4-((3-(4-cyclohexylpiperazin-1-yl)-6-oxo-6H-anthra[1,9-cd]isoxazol-5-yl)amino)benzoic acid

• CAT Number: L018218
• CAS Number: 892242-64-7
• Molecular Formula: C31H30N4O4
• Molecular Weight: 522.60
• Purity: ≥95%
• IUPAC Name: 4-[[12-(4-cyclohexylpiperazin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid
• InChI: InChI=1S/C31H30N4O4/c36-29-22-8-4-5-9-23(22)30-27-26(29)24(32-20-12-10-19(11-13-20)31(37)38)18-25(28(27)33-39-30)35-16-14-34(15-17-35)21-6-2-1-3-7-21/h4-5,8-13,18,21,32H,1-3,6-7,14-17H2,(H,37,38)
• InChIKey: MMUWXZUTOXDAGI-UHFFFAOYSA-N
• SMILES: C1CCC(CC1)N2CCN(CC2)C3=CC(=C4C5=C(C6=CC=CC=C6C4=O)ON=C35)NC7=CC=C(C=C7)C(=O)O

4-((3-(4-Cyclohexylpiperazin-1-yl)-6-oxo-6H-anthra[1,9-cd]isoxazol-5-yl)amino)benzoic acid（Cat No.:L018218）is a complex organic compound used in advanced pharmaceutical research. This molecule features a combination of cyclohexylpiperazine, anthra[1,9-cd]isoxazole, and benzoic acid moieties, which contribute to its potential bioactivity. It is studied for its role as a potential therapeutic agent, particularly in targeting specific biological pathways. The compound’s intricate structure allows it to interact with multiple molecular targets, making it valuable for drug discovery and development in oncology and other therapeutic areas.